Experimental bladder carcinogenesis-rodent models

Experimental Oncology

Volumn 28, Issue 1, 2006, Pages 2-11

  Oliveira, P A ^a   Colaco A ^a   De La Cruz P, L F ^b   Lopes, C ^c,d  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b University of Santiago de Compostcla   (Spain)

^c PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

Bladder cancer; Mice; Rat; Rodent model

Indexed keywords

CARCINOGEN; HYPERICIN; METHYLNITROSOUREA; N (2 FLUORENYL)ACETAMIDE; N [4 (5 NITRO 2 FURYL) 2 THIAZOLYL]FORMAMIDE; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; NITROSAMINE; PROTOPORPHYRIN; SULFONAMIDE; TUMOR PROMOTER;

BLADDER; BLADDER CANCER; BLADDER CARCINOGENESIS; BRACKEN FERN; CANCER THERAPY; CANCER TRANSPLANTATION; CELL CULTURE; CHEMOPROPHYLAXIS; DISEASE MODEL; FOREIGN BODY; HUMAN; IMAGING; IMPLANTATION; IONIZING RADIATION; NEOPLASM; NONHUMAN; ONCOGENE C H RAS; PHOTODYNAMIC THERAPY; REVIEW; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; URINE CYTOLOGY; UROLITHIASIS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARCINOGENS; DISEASE MODELS, ANIMAL; GENETIC ENGINEERING; HUMANS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RODENTIA; URINARY BLADDER NEOPLASMS;

EID: 33646019838     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Airoldi L, Magagnotti C, Bonfanti M, Fanelli R. Alpha-oxidative metabolism of the bladder carcinogens N-nitrosobutyl(4-hydroxybutyl)amine and N-nitrosobutyl(3-carboxypropyl) amine within the rat isolated bladder. Carcinogenesis 1990; 11: 1437-40.
2. Akagi G, Akagi A, Kimura M, Otsuka H. Comparison of bladder tumors induced in rats and mice with N-butyl-N-(4-hydroxybutyl) nitrosoamine. Gan 1973; 64: 331-6.
3. Alexander B, Makar AA, Hopster D, O'Donnell, PJ, Coptcoat MJ, Muir G. Development of bladder urothelial hyperplasia and carcinoma in portacaval shunted rats is not dependent upon urolithiasis. Exp Mol Pathol 2004; 77: 205-59.
4. Armstrong EC, Bonser GM. Epithelial tumours of the urinary bladder in mice induced by 2-acetylamino-fluorine. J Pathol 1944; 6: 506-12.
5. Asanuma H, Arai T, Seguchi K, Kawauchi S, Satoh H, Kikuchi M, Murai M. Successful diagnosis of orthotopic rat superficial bladder tumor model by ultrathin cystoscopy. J Urol 2003; 169: 718-20.
6. Becci PJ, Thompson HJ, Strum JM, Brown CC, Spor MB, Moon RC. N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids. Cancer Res 1981; 41: 927-32.
7. Bertram JS, Craig AW. Specific induction of bladder cancer in mice by butyl-(4-hydroxybutyl)-nitrosamine and the effects of hormonal modifications on the sex difference in response. Eur J Cancer 1972; 8: 587-94.
8. Bisson JF, Christophe M, Padilla-Ybarra JJ, Notter D, Vigneron C, Guillemin F. Determination of the maximal tumor: normal bladder ratio after i.p. or bladder administration of 5-aminolevulinic acid in Fischer 344 rats by fluorescence spectroscopy in situ. Anticancer Drugs 2002; 13: 851-7.
9. Bonfanti M, Magagnotti C, Bonati M, Fanelli R, Airoldi L. Pharmacokinetic profile and metabolism of N-nitrosobutyl-(4-hydroxybutyl) amine in rats. Cancer Res 1988; 48: 3666-9.
10. Boorman GA. Animal model of human disease: carcinoma of the ureter and urinary bladder. Am J Pathol 1977; 88: 251-4.
11. Boorman GA, Wood M, Fukushima S. Tumours of the urinary bladder. IARC Sci Publ 1994; 111: 383-406.
12. Bryan GT. Pellet implantation studies of carcinogenic compounds. J Natl Cancer Inst 1969; 43: 255-61.
13. Chapman WH, Kirchheim D, McRoberts JW. Effect of the urine and calculus formation on the incidence of bladder tumors in rats implanted with paraffin wax pellets. Cancer Res 1973; 33: 1225-9.
14. Clayson DB. Editorial: bladder carcinogenesis in rats and mice: possibility of artifacts. J Natl Cancer Inst 1974; 52: 1685-9.
15. Clayson DB, Cooper EH. Cancer of the urinary tract. Adv Cancer Res 1970; 13: 271-381.
16. Clayson DB, Fishbein L, Cohen SM. Effects of stones and other physical factors on the induction of rodent bladder cancer. Food Chem Toxicol 1995; 33: 771-84.
17. Cohen AE, Weisburger EK, Weisburger JH, Ward JM, Putnam CL. Cystoscopy of chemically induced bladder neoplasms in rabbits administered the carcinogen dibutylnitrosamine. Invest Urol 1975; 12: 262-6.
18. Cohen SM. Cell proliferation and carcinogenesis. Drug Metab Rev 1998; 30: 339-57.
19. Cohen SM. Urinary bladder carcinogenesis. Toxicol Pathol 1998; 26: 121-7.
20. Cohen SM. Comparative pathology of proliferative lesions of the urinary bladder. Toxicol Pathol 2002; 30: 663-71.
21. Cohen SM, Friedell GH. In: The mouse in biomedical research. Neoplasms of the urinary system. Chapter 24. New York: Academic press, 1982: 439-63.
22. Cohen SM, Jacobs JB, Arai M, Johansson S, Friedell GH. Early lesions in experimental bladder cancer: experimental design and light microscopic findings. Cancer Res 1976; 36: 2508-11.
23. Cohen SM, Lawson TA. Rodent bladder tumors do not always predict for humans. Cancer Lett 1995; 93: 9-16.
24. DeSesso JM. Confounding factors in direct bladder exposure studies. Comments Toxicol 1989; 3: 317-34.
25. DeSesso JM. Anatomical relationships of urinary bladders compared: their potential role in the development of bladder tumours in humans and rats. Food Chem Toxicol 1995; 33: 705-14.
26. Duy N, Yanaguchi Y, Prabhudescri M, Babb J, Gans H. Cancer of the bladder in the portacaval shunted rat. Gastrenterology 1981; 80: 1331-6.
27. Dybing E, Sanner T. Species differences in chemical carcinogenesis of the thyroid gland, kidney and urinary bladder. IARC Sci Publ 1999; 147: 15-32.
28. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 1435-48.
29. Erturk E, Cohen SM, Bryan GT. Induction, histogenesis, and isotransplanta bility of renal tumors induced by formic acid 2-[4-(5-nitro-2-furyl)-2- triazolyl]-hydrazide in rats. Cancer Res 1970; 30: 2098-106.
30. Frith CH, Eighmy JJ, Fukushima S, Cohen SM, Squire RA, Chandra M. In: Guide for Toxicol Pathol. Proliferative lesions of the lower urinary tract in rats. Washington: STP/ARP/AFIP, 1995: 1-13.
31. Fukushima S. Modification of tumor development in the urinary bladder. Prog Exp Tumor Res 1991; 33: 154-74.
32. Fukushima S, Friedell GH, Jacobs JB, Cohen SM. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Cancer Res 1981; 41: 3100-3.
33. Fukushima S, Imaida K, Sakata T, Okamura T, Shibata M, Ito N. Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats. Cancer Res 1983; 43: 4454-7.
34. Fukushima S, Murai T. Calculi, precipitates and microcrystalluria associated with irritation and cell proliferation as a mechanism of urinary bladder carcinogenesis in rats and mice. IARC Sci Publ 1999; 147: 159-74.
35. Gollapudi BB, Stott WT, Yano BL, Bus JS. Mode of action considerations in the use of transgenic animals for mutagenicity and carcinogenicity evaluations. Toxicol Lett 1998; 102-103: 479-84.
36. Grippo PJ, Sandgren EP. Modeling pancreatic cancer in animals to address specific hypothesis. Meth Mol Med 2005; 103: 217-43.
37. Gunther JH, Jurczok A, Wulf T, Brandau S, Deinert I, Jocham D, Bohle A. Optimizing syngeneic orthotopic murine bladder cancer (MB49). Cancer Res 1999; 59: 2834-7.
38. Gunther JH, Frambach M, Deinert I, Brandau S, Jocham D, Bohle A. Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49). J Urol 1999; 161: 1702-6.
39. Hirose M, Fukushima S, Hananouchi M, Shirai T, Ogiso T. Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds. Gan 1976; 67: 175-89.
40. Hueper WC. Aniline tumors of the bladder. Arch Pathol 1938; 25: 858.
41. Huland H, Otto U, von Paleske A. Chemotherapy and human bladder carcinoma transplanted into NMRI nu/nu mice. J Urol 1985; 134: 601-6.
42. Ibrahiem EH, Nigam VN, Brailovsky CA, Madarnas P, Elhilali M. Orthotopic implantation of primary N-[4-(5-Nitro-2-furyl)-2-thiazolyl] formamide-induced bladder cancer in bladder submucosa: an animal model for bladder cancer study. Cancer Res 1983; 43: 617-22.
43. Ito N, Fukushima S. Promotion of urinary bladder carcinogenesis in experimental animals. Exp Pathol 1989; 36: 1-15.
44. Iwata H, Otoshi T, Takada N, Murai T, Tamano S, Watanabe T, Katsura Y, Fukushima S. Validation of silver-stained nucleolar organizer regions for evaluation of invasive character of urinary bladder carcinoma in rats and mice. Urol Res 1995; 23: 27-32.
45. Jaffe V, Alexander B, Price AB, Zanelli GD. The induction of bladder cancer in portally diverted rats. Br J Cancer 1992; 66: 470-3.
46. Janzowski C, Jacob D, Henn I, Zankl H, Poole-Zobel BL, Eisenbrand G. Investigations on organ-specific metabolism and genotoxic effects of the urinary N-nitrosodibutylamine (NDBA) and N-nitrosobutyl-4-hydroxybutylamine (4-OH-NDBA). Toxicology 1989; 59: 195-209.
47. Jull JW. The induction of tumours of the bladder epithelium in mice by the direct application of a carcinogen. Br J Cancer 1951; 5: 328-30.
48. Jull JW. The effect of time on the incidence of carcinomas obtained by the implantation of paraffin wax pellets into mouse bladder. Cancer Lett 1979; 6: 21-5.
49. Kamuhabwa AA, Cosserat-Gerardin I, Didelon J, Notter D, Guillemin F, Roskams T, D'Hallewin MA, Baert L, de Witte PA. Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy. Int J Cancer 2002; 97: 253-60.
50. Kunze E. Hyperplasia urinary bladder rat. In: Monographs on Pathology of laboratory animals. Urinary system. Second edition. Jones TC, Hard GC, Mohr U, eds. Springer, New York. 1998: 331-68.
51. Kunze E, Chowaniec J. Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the urinary bladder. IARC Sci Publ 1990; 99: 345-97.
52. Kunze E, Gassner G. Modification of N-methyl-N-nitrosourea-induced urinary bladder carcinogenesis in rats following stimulation of urothelial proliferation by a partial cystectomy. J Cancer Res Clin Oncol 1986; 112: 11-8.
53. Kunze E, Graewe T, Scherber S, Weber J, Gellhar P. Cell cycle dependence of N-methyl-N-nitrosourea-induced tumour development in the proliferating, partially resected rat urinary bladder. Br J Exp Pathol 1989; 70: 125-42.
54. Kunze E, Konnecke B, Nienaber C. Development of N-butyl-N-(hydroxybutyl)- nitrosamine-induced tumors in the partially resected, proliferating rat urinary bladder in dependence upon the time of onset of stimulated DNA synthesis. Urol Res 1990; 18: 319-22.
55. Kunze E, Schauer A, Schatt S. Stages of transformation in the development of N-butyl-transitional cell carcinomas in the urinary bladder of rats. Z Krebsforsch Klin Onkol 1976; 87: 139-60.
56. Lalich JJ. Experimentally induced uracil urolithiasis in rats. J Urol 1966; 95: 83-6.
57. Magee PN, Barnes JM. Carcinogenic nitroso compounds. Adv Cancer Res 1967; 10: 163-246.
58. Mann AM, Masui T, Chlapowski FJ, Okamura T, Borgeson CD, Cohen SM. In vitro transformation of rat bladder epithelium by 2-amino-4-(5-nitro-2-furyl) thiazole. Carcinogenesis 1991; 12: 417-22.
59. Masters JR, Petzoldt JL. In vitro studies on the pathogenesis of bladder cancer. Verh Dtsch Ges Pathol 1993; 77: 157-60.
60. Masui T, Dong Y, Yamamoto S, Takada N, Nakanishi H, Inada K, Fukushima S, Tatematsu M. p53 mutations in transitional cell carcinomas of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine. Cancer Lett 1996; 105: 105-12.
61. Masuko T, Sugahara K, Nakajima S, Hashimoto Y. Altered expression of immunohistochemically detected cytochrome P-450 component(s) in nitrosamine-induced rat urinary bladder lesion. Jpn J Cancer Res 1987; 78: 840-5.
62. Miller JA. Carcinogenesis by chemicals: an overview - G.H.A. Clowes memorial lecture. Cancer Res 1970; 30: 559-76.
63. Murphy WM, Nagy GK, Rao MK, Soloway MS, Parija GC, Cox CE, 2nd Friedell GH. "Normal" urothelium in patients with bladder cancer: a preliminary report from the National Bladder Cancer Collaborative Group A. Cancer 1979; 44: 1050-8.
64. Murphy WM, Irving CC. The cellular features of developing carcinoma in murine urinary bladder. Cancer 1981; 47: 514-22.
65. Murphy WM, Soloway MS. The effect of thio-TEPA on developing and established mammalian bladder tumors. Cancer 1980; 45: 870-5.
66. Murphy WM, Soloway MS, Lin CJ. Morphologic effects of thio-TEPA on mammalian urothelium. Changes in abnormal cells. Acta Cytol 1978; 22: 550-4.
67. Ogawa K, Kimoto N, Asamoto M, Nakanishi M, Takahashi S, Shirai T. Aberrant expression of p27(Kip1) is associated with malignant transformation of the rat urinary bladder epithelium. Carcinogenesis 2000; 21: 117-21.
68. Ohtani M, Kakizoe T, Nishio Y, Sato S, Sugimura T, Fukushima S, Niijima T. Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl) nitrosamine. Cancer Res 1986; 46: 2001-4.
69. Okajima E, Hiramatsu T, Hirao K, Ijuin M, Hirao Y, Babaya K, Ikuma S, Ohara S, Shiomi T, Hijioka T, Ohishi H. Urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in dogs. Cancer Res 1981; 41: 1958-66.
70. Oliveira PA, Palmeira C, Lourenço L, Lopes C. Evaluation of DNA content in preneoplastic changes of mouse urinary bladder induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. J Exp Clin Cancer Res 2005; 24: 207-14.
71. Ota T, Asamoto M, Toriyama-Baba H, Yamamoto F, Matsuoka Y, Ochyia T, Sekiya T, Terada M, Akaza H, Tsuda H. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis. Carcinogenesis 2000; 21: 1391-6.
72. Oyasu R. Epithelial tumours of the lower urinary tract in humans and rodents. Food Chem Toxicol 1995; 33: 747-55.
73. Oyasu R, Iwasaki T, Matsumoto M, Hirao Y, Tabuchi Y. Induction of tumors in heterotopic bladder by topical application of N-methyl-N-nitrosourea and N-butyl-N-(3-carboxypropyl) nitrosamine. Cancer Res 1978; 38: 3019-25.
74. Ozaki K, Sukata T, Yamamoto S, Uwagawa S, Seki T, Kawasaki H, Yoshitake A, Wanibuchi H, Koide A, Mori Y, Fukushima S. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl) nitrosamine urinary bladder Carcinogenesis and lack of frequent mutation in residual allele. Cancer Res 1998; 58: 3806-11.
75. Pamukcu AM, Erturk E, Yalciner S, Bryan GT. Histogenesis of urinary bladder cancer induced in rats by bracken fern. Invest Urol 1976; 14: 213-8.
76. Perabo FG, Demant AW, Wirger A, Schmidt DH, Sitia M, Wardelmann E, Muller SC, Kohn EC. Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model. Anticancer Res 2005; 25: 725-9.
77. Raghavan D, Debruyne F, Herr H, Jocham D, Kakizoe T, Okajima E, Sandberg A, Tannock I. In: Developments in Bladder cancer. Experimental models of bladder cancer: A critical review. Alan R. New York: Liss, Inc., 1986: 171-208.
78. Ratliff TL, Palmer JO, McGarr JA, Brown EJ. Intravesical Bacillus Calmette-Guerin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guerin. Cancer Res 1987; 47: 1762-6.
79. Russell PJ, Jingsley EA. In: Bladder cancer biology, diagnosis and management. Animal models for the study of bladder cancer. Syrigos NK, Skinner DG, eds. New York: Oxford University Press, 1999: 71-95.
80. Russell PJ, Raghavan D, Gregory P, Philips J, Wills EJ, Jelbart M, Wass J, Zbroja RA, Vincent PC. Bladder cancer xenografts: a model of tumor cell heterogeneity. Cancer Res 1986; 46: 2035-40.
81. Sardon D, de la Fuente I, Calonge E, Perez-Alenza MD, Castano M, Dunner S, Pena L. H-ras immunohistochemical expression and molecular analysis of urinary bladder lesions in grazing adult cattle exposed to bracken fern. J Comp Pathol 2005; 132: 195-201.
82. Sens DA, Park S, Gurel V, Sens MA, Garrett SH, Somji S. Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells. Toxicol Sci 2004; 79: 56-63.
83. Shirai T. Etiology of bladder cancer. Semin Urol 1993; 11: 113-26.
84. Shirai T, Fukushima S, Hirose M, Ohshima M, Ito N. Epithelial lesions of the urinary bladder in three hundred and thirteen autopsy cases. Jpn J Cancer Res 1987; 78: 1073-80.
85. Shirai T, Shibata M, Takahashi S, Tagawa Y, Imaida K, Hirose M. Differences in cell proliferation and apoptosis between reversible and irreversible mucosal lesions associated with uracil-induced urolithiasis in N-butyl-N-(4-hydroxybutyl)nitrosamine-pretreated. Carcinogenesis 1995; 16: 501-5.
86. Shirai T, Takahashi S. In: Monographs on pathology of laboratory animals. Papilloma, urinary bladder, rat. Urinary system. Second edition. Jones TC, Hard GC, Mohr U, eds. New York: Springer, 1998: 399-402.
87. Smith BL, Seawright AA, Ng JC, Hertle AT, Thomson JA, Bostock PD. Concentration of ptaquiloside, a major carcinogen in bracken fern (Pteridium spp.), from eastern Australia and from a cultivated worldwide collection held in Sydney, Australia. Nat Toxins 1994; 2: 347-53.
88. Soloway MS. Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res 1977; 37: 2918-29.
89. Spry LA, Zenser TV, Cohen SM, Davis BB. Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat. J Clin Invest 1985; 76: 1025-31.
90. Squire RA. In: Monographs on pathology of laboratory animals. Urinary system. Second edition. Classification and differential diagnosis of neoplasms, urinary tract, rat. Jones TC, Hard GC, Mohr U, eds. New York: Springer, 1998: 69-74.
91. Steinberg GD, Brendler CB, Squire RA, Isaacs JT. Experimental intravesical therapy for superficial transitional cell carcinoma in a rat bladder tumor model. J Urol 1991; 145: 647-53.
92. Stewart FA, Denekamp J, Hirst DG. Proliferation kinetics of the mouse bladder after irradiation. Cell Tissue Kinet 1980; 13: 75-89.
93. Tamano S, Hagiwara A, Suzuki E, Okada M, Shirai T, Fukushima S. Time- and dose-dependent induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine in B6C3F1 mice. Jpn J Cancer Res 1991; 82: 650-6.
94. Tsuda H, Fukamachi K, Ohshima Y, Ueda S, Matsuoka Y, Hamaguchi T, Ohnishi T, Takasuka N, Naito A. High susceptibility of human c-Ha-ras proto-oncogene transgenic rats to carcinogenesis: a cancer-prone animal model. Cancer Sci 2005; 96: 309-16.
95. Tsuda H, Miyata Y, Hagiwara A, Hasegawa R, Shirai T, Ito N. Damage and repair of DNA in urinary bladder epithelium of rats treated with N-butyl-N-(4-hydroxybutyl) nitrosamine. Gan 1977; 68: 781-3.
96. Xiao Z, McCallum TJ, Brown KM, Miller GG, Halls SB, Parney I, Moore R. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Br J Cancer 1999; 81: 638-46.
97. Xiao Z, Brown K, Tulip J, Moore RB. Whole bladder photodynamic therapy for orthotopic superficial bladder cancer in rats: a study of intravenous and intravesical administration of photosensitizers. J Urol 2003; 169: 352-6.
98. Yamagiwa K and Ichikawa K. Experimental study of the pathogenesis of carcinoma. J Cancer Res 1918; iii: 1-29.
99. Yamamoto S, Min W, Lee CC, Salim EI, Wanibuchi H, Sukata T, Fukushima S. Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl) nitrosamine. Cancer Lett 1999; 135: 137-44.